|
| Status |
Public on Feb 07, 2013 |
| Title |
MiRNA/gene profiling unveils early molecular changes and NRF2 activation in a rat model recapitulating human HCC |
| Organism |
Rattus norvegicus |
| Experiment type |
Expression profiling by array
|
| Summary |
Studies on gene and/or microRNA (miRNA) dysregulation in the early stages of hepatocarcinogenesis are hampered by the difficulty of diagnosing early lesions in humans. Experimental models recapitulating human hepatocellular carcinoma (HCC) are then entailed to perform this analysis. We performed miRNA and gene expression profiling to characterize the molecular events involved in the multistep process of hepatocarcinogenesis in the Resistant-Hepatocyte rat model. A high percentage of dysregulated miRNAs/genes in HCC were similarly altered in early preneoplastic lesions positive for the stem/progenitor cell marker cytokeratin-19, indicating that several HCC-associated alterations occur from the very beginning of the carcinogenic process. Our analysis also identified miRNA/gene-target networks aberrantly activated at the initial stage of hepatocarcinogenesis. Activation of the NRF2 pathway and up-regulation of the miR-200 family were among the most prominent changes. The relevance of these alterations in the development of HCC was confirmed by the observation that NRF2 silencing impaired while miR-200a overexpression promoted HCC cell proliferation in vitro. Moreover, T3-induced in vivo inhibition of the NRF2 pathway accompanied the regression of cytokeratin-19 positive nodules, suggesting that activation of this transcription factor contributes to the onset and progression of preneoplastic lesions towards malignancy. The finding that 78% of genes and 57% of dysregulated miRNAs in rat HCC have been previously associated to human HCC as well underlines the translational value of our results. Conclusions: this study indicates that most of the molecular changes found in HCC occur in the very early stages of hepatocarcinogenesis. Among these, the NRF2 pathway plays a relevant role and may represent a new therapeutic target.
|
| |
|
| Overall design |
20 nodules (10 weeks after initiation with DENA), 4 adenomas (10 months), 5 eHCCs (10 months) and 9 aHCCs (14 months) were dissected. 10 controls also included.
|
| |
|
| Contributor(s) |
Sulas P |
| Citation(s) |
23857252 |
| Submission date |
Feb 06, 2013 |
| Last update date |
Jul 29, 2014 |
| Contact name |
Davide Cora' |
| E-mail(s) |
davide.cora@ircc.it, davide.cora@uniupo.it
|
| Phone |
+390321660631
|
| Organization name |
Piemonte Orientale University and IRCCS Candiolo Cancer Institute
|
| Department |
Dept. of Oncology
|
| Lab |
Vascular Oncology
|
| Street address |
Str. Prov. 142 Km. 3.95
|
| City |
Candiolo |
| State/province |
TO |
| ZIP/Postal code |
I-10060 |
| Country |
Italy |
| |
|
| Platforms (1) |
| GPL6101 |
Illumina ratRef-12 v1.0 expression beadchip |
|
| Samples (48)
|
|
| Relations |
| BioProject |
PRJNA188681 |
Less...
More...